This year’s exhibition was held in Barcelona, Spain, and aims to establish partnerships between participants, develop the international pharmaceutical community and open up new business opportunities.
Farmak’s portfolio includes more than 450 pharmaceutical products. This year, the focus at the international fair was on medicinal products used in anaesthesiology and intensive care, diagnostic imaging, anaemia treatment, anti-inflammatory drugs and painkillers.
Among Ukrainian pharmaceutical companies, Farmak has the highest number of GMP certificates issued by European regulatory bodies. These cover the production of medicines in various forms, ranging from tablets, capsules, ointments, suppositories, emulsions, suspensions, as well as product quality control operations.
Farmak is the leader of the pharmaceutical market in Ukraine*, the country’s largest exporter and the most expensive brand in the industry**, and one of the 1,000 largest producers of medicinal products in the world. Farmak’s medicinal products are sold in Europe, including the EU, Asia, Central and South America, the Middle East and Australia. The company has representative offices in Uzbekistan, Kazakhstan, Kyrgyzstan and Vietnam. International offices in Poland and the United Arab Emirates, as well as marketing companies in the Czech Republic and Slovakia.
It is symbolic that in 2024, Farmak’s new production facility is due to open in the same city where CPHI Worldwide took place this week, Barcelona, Spain. There will be more Ukrainian medicines in Europe!
*According to Proxima Research
**According to MPP Consulting 2023 study